IP Library Granted Patent US 7,311,689
Granted Patent B2
US 7,311,689 · App. 10/642,638 · Granted Dec 25, 2007

Method and apparatus for peripheral vein fluid removal in heart failure

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,311,689
App. No.
10/642,638
Granted
Dec 25, 2007
Kind
B2
Abstract

A method and apparatus for ultrafiltration of blood operating by removing blood from a peripheral blood vessel at a rate of less than two percent of total cardiac output of a patient, extracting fluid at a rate of 0.1 liter to 1.0 liters per hour while retaining cells and proteins in the blood, and returning the concentrated blood to a secondary blood vessel is disclosed. Blood is removed and returned using small gage needles. As a pump circulates blood from the patient, a filter removes ultrafiltrate from the blood using duty cycle or pump control, and a transparent container collects the removed fluid.

Claims (37)

1. A method for filtering blood comprising:

withdrawing blood from an adult patient;

performing ultrafiltration by filtering the withdrawn blood in a filter having an active filter membrane surface of no greater than 0.2 meters squared (m 2 ) to remove ultrafiltrate from the blood, wherein the filter membrane blocks passage of blood molecules having a molecular weight of at least 60,000 Daltons, wherein an amount of the removed ultrafiltrate is an effective therapeutic amount for treating a fluid overload condition of the patient;

infusing the ultrafiltrated blood into the adult patient, and

withdrawing the blood in a range of 10 to 60 milliliters per minute.

2. A method as in claim 1 wherein the ultrafiltrate is removed at a rate determined by a mechanical filtrate pump and said method further comprising concentrating the blood by removal of the ultrafiltrate.

3. A method for filtering blood comprising:

withdrawing blood from an adult patient;

performing ultrafiltration by filtering the withdrawn blood in a filter having an active filter membrane surface of no greater than 0.2 meters squared (m 2 ) to remove ultrafiltrate from the blood, wherein the filter membrane blocks passage of blood molecules having a molecular weight of at least 60,000 Daltons, wherein an amount of the removed ultrafiltrate is an effective therapeutic amount for treating a fluid overload condition of the patient;

infusing the ultrafiltrated blood into the adult patient, and

passing the blood through a blood circuit comprising the filter during a residence time period of no greater than 120 seconds.

4. A method as in claim 3 further comprising passing the blood through filter fibers having a length of at least 20 centimeters and wherein said filter fibers are housed in a substantially straight filter housing.

5. A method as in claim 3 further comprising passing the blood through a straight bundle of filter fibers having at least 620 fibers.

6. A method as in claim 3 wherein said filter further comprises a substantially straight housing having a length of at least 20 cm and an internal diameter of no greater than 1.5 cm.

7. A method for filtering blood comprising:

withdrawing blood from an adult patient;

performing ultrafiltration by filtering the withdrawn blood in a filter having an active filter membrane surface of no greater than 0.2 meters squared (m 2 ) to remove ultrafiltrate from the blood, wherein the filter membrane blocks passage of blood molecules having a molecular weight of at least 60,000 Daltons, wherein an amount of the removed ultrafiltrate is an effective therapeutic amount for treating a fluid overload condition of the patient;

infusing the ultrafiltrated blood into the adult patient, and

a shear rate of blood flowing through the filter of at least 1000 per second at a flow rate of no greater than 40 ml/sec.

8. A method as in any of claims 1 , 3 or 7 wherein the filter membrane blocks passage of blood molecules having a molecular weight of at least 50,000 Daltons.

9. A method as in any of claims 1 , 3 or 7 wherein the filter membrane blocks passage of blood molecules having a molecular weight of at least 30,000 Daltons.

10. A method as in any of claims 1 , 3 or 7 wherein the filter membrane blocks passage of blood molecules having a molecular weight of 20,000 Daltons.

11. A method for filtering blood comprising:

withdrawing blood from an adult patient;

performing ultrafiltration by filtering the withdrawn blood in a filter having an active filter membrane surface of no greater than 0.2 meters squared (m 2 ) to remove ultrafiltrate from the blood, wherein the filter membrane inhibits the passage of plasma proteins and an amount of the removed ultrafiltrate is an effective therapeutic amount for treating a fluid overload condition of the patient;

infusing the ultrafiltrated blood into the adult patient, and

withdrawing the blood in a range of 10 to 60 milliliters per minute.

12. A method for filtering blood comprising:

withdrawing blood from an adult patient;

performing ultrafiltration by filtering the withdrawn blood in a filter having an active filter membrane surface of no greater than 0.2 meters squared (m 2 ) to remove ultrafiltrate from the blood, wherein the filter membrane inhibits the passage of plasma proteins and an amount of the removed ultrafiltrate is an effective therapeutic amount for treating a fluid overload condition of the patient;

infusing the ultrafiltrated blood into the adult patient, and

passing the blood through a blood circuit comprising the filter during a residence time period of no greater than 120 seconds.

13. A method for filtering blood comprising:

withdrawing blood from an adult patient;

performing ultrafiltration by filtering the withdrawn blood in a filter having an active filter membrane surface of no greater than 0.2 meters squared (m 2 ) to remove ultrafiltrate from the blood, wherein the filter membrane inhibits the passage of plasma proteins and an amount of the removed ultrafiltrate is an effective therapeutic amount for treating a fluid overload condition of the patient;

infusing the ultrafiltrated blood into the adult patient, and

a shear rate of blood flowing through the filter of at least 1000 per second at a flow rate of no greater than 40 ml/sec.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2015
From: GAMBRO UF SOLUTIONS, INC.
To: GAMBRO LUNDIA AB
Reel/Frame 036502/0913 →
CHANGE OF NAME Recorded Aug 25, 2015
From: CHF SOLUTIONS, INC.
To: GAMBRO UF SOLUTIONS, INC.
Reel/Frame 036412/0797 →
CHANGE OF NAME Recorded Aug 21, 2015
From: INTELLICARDIA, INC.
To: CHF SOLUTIONS, INC.
Reel/Frame 036390/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2015
From: LEVIN, HOWARD R.; GELFAND, MARK; O'MAHONY, JOHN; POLASCHEGG, HANS-DIETRICH
To: INTELLICARDIA INC.
Reel/Frame 036162/0364 →